Genitope stops cancer vaccine program, looking at finances
March 10 |
March 10 (Reuters) - Genitope Corp GTOP.O said it will stop the development of its cancer vaccine MyVax, which failed late-stage trials last year.
The company said it is evaluating its financial position and plans for continued operations. (Reporting by Varsha Tickoo in Bangalore; Editing by Anil D'Silva)
- Tweet this
- Share this
- Digg this